Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Moodys
Healthtrust
Citi
Accenture
Argus Health
AstraZeneca
Queensland Health
Boehringer Ingelheim

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,934,032

« Back to Dashboard

Summary for Patent: 3,934,032
Title: Alkanolamine derivatives for treating hypertension
Abstract:1-(ELECTRONEGATIVELY-SUBSTITUTED-ALKYL- OR ALKENYLPHENOXY)-3-ALKYLAMINO-2-PROPANOL DERIVATIVES, FOR EXAMPLE 1-P-CARBAMOYLMETHYLPHENOXY-3-ISOPROPYLAMINO-2-PROPANOL, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM POSSESS .beta.-ADRENERGIC BLOCKING ACTIVITY AND ARE USEFUL IN THE TREATMENT OF HEART DISEASES AND OTHER COMPLAINTS IN MAN.
Inventor(s): Barrett; Arthur Michael (Leeds, EN), Carter; John (Macclesfield, EN), Hull; Roy (Macclesfield, EN), Le Count; David James (Macclesfield, EN), Squire; Christopher John (Macclesfield, EN)
Assignee: Imperial Chemical Industries Limited (London, EN)
Application Number:05/461,262
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 3,934,032

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 3,934,032

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
9445/69Feb 21, 1969
47048/69Sep 24, 1969
55028/70Nov 19, 1970
53544/71Nov 18, 1971

International Patents Family Members for US Patent 3,934,032

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 303005 ➤ Try a Free Trial
Austria 304472 ➤ Try a Free Trial
Austria 305244 ➤ Try a Free Trial
Austria 305245 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
Baxter
Julphar
Cipla
Teva
McKesson
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.